TABLE 4.
Description of myasthenia gravis‐related healthcare resource utilization during the study follow‐up periods.
| Parameter | Year 1–2 (N = 219) | Year 3–4 (N = 164) | Year 5–6 (N = 124) | Year 7–8 (N = 94) |
|---|---|---|---|---|
| Ambulatory neurologist consultations (per patient/year) | 1916 (4.38) | 1075 (3.28) | 720 (2.67) | 495 (2.38) |
| Other specialist consultations (per patient/year) | 340 (0.78) | 123 (0.38) | 96 (0.39) | 52 (0.28) |
| Hospital admission due to MG or complications (days per patient/year) | 1249 (2.85) | 267 (0.82) | 280 (1.13) | 53 (0.28) |
| Hospitalization due to thymectomy (days per patient/year) | 479 (1.09) | NA | NA | NA |
| Day hospital sessions (days per patient/year) | 458 (1.05) | 157 (0.48) | 122 (0.49) | 8 (0.04) |
| ER consultations due to MG (per patient/year) | 20 (0.05) | 22 (0.07) | 12 (0.05) | 0 |
| ICU admission (days per patient/ year) | 81 (0.18) | 13 (0.04) | 50 (0.20) | 62 (0.33) |
| Total amount of IVIG in grams (per patient/year) | 24,138 (55.11) | 7650 (23.32) | 5590 (22.54) | 2195 (11.67) |
| PLEX sessions (per patient/year) | 90 (0.21) | 23 (0.07) | 25 (0.10) | 0 |
| Estimated costs of MG care (per patient/year) | 3,496,952.65 € (8074.19 €) | 748,132.75 € (2280.89 €) | 689,793.58 € (2774.09 €) | 315,739.24 € (1679.46 €) |
Note: Total and mean number per patient/year are shown for each timepoint analyzed. Data about health care consumption per patient and year are shown in parentheses.
Abbreviations: ER, emergency room; ICU, intensive care unit; IVIG, intravenous immunoglobulin; MG, myasthenia gravis; NA, not applicable; PLEX, plasma exchange.